Allen Loyd V, Okeke Claudia C
International Journal of Pharmaceutical Compounding, Edmond, Oklahoma.
Int J Pharm Compd. 2007 Jul-Aug;11(4):313-23.
United States Pharmacopeia Chapter 797 Pharmaceutical Compounding-Sterile Preparations pertains to all preadministration manipulations and procedures involved in preparation of sterile compounds for application, implantation, infusion, inhalation, injection, insertion, instillation, or irrigation, including preparation, storage, and transportation. The chapter does not pertain to actual clinical administration of compounded sterile preparations to patients. The intent of Chapter 797 is simply to prevent patient harm and fatalities that may result from nonsterility, excessive endotoxin load, large content errors in strength of correct ingredients, or the presence of incorrect ingredients. Because the achievement of sterility requires that facilities meet minimum cleanliness standards, that personnel be trained adequately and undergo periodic testing and training in sterilization techniques, and that appropriate principles and practices be applied to sustain solution stability, compliance to Chapter 797 should be the goal of any facility where sterile preparations are compounded. Many pharmacies have already become compliant with Chapter 797, and those that have already met the new standards seem to support them strongly.
《美国药典》第797章“药物配制 - 无菌制剂”适用于为应用、植入、输注、吸入、注射、插入、滴注或冲洗而制备无菌化合物所涉及的所有给药前操作和程序,包括制备、储存和运输。本章不适用于将配制好的无菌制剂实际临床给予患者的过程。第797章的目的仅仅是防止因非无菌、内毒素负荷过高、正确成分强度的大量含量误差或存在不正确成分而可能导致的患者伤害和死亡。由于实现无菌要求设施符合最低清洁标准,人员接受充分培训并定期接受灭菌技术测试和培训,以及应用适当的原则和实践来维持溶液稳定性,因此遵守第797章应该是任何配制无菌制剂的机构的目标。许多药房已经符合第797章的要求,那些已经达到新标准的药房似乎强烈支持这些标准。